Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Efficacy of brachytherapy with californium-252 neutrons versus cesium-137 photons for eradication of bulky localized cervical cancer: single-institution study

Journal Article · · JNCI, J. Natl. Cancer Inst.; (United States)

A fast-neutron-emitting radioisotope, /sup 252/Cf, is being tested in clinical trials of neutron brachytherapy for cervical cancer. The efficacy for histological eradication of bulky stage IB cervical tumors (mean diameter, approximately 6 cm) using combined radiation and surgery was studied in 65 patients treated with /sup 137/Cs or /sup 252/Cf before surgery during 1983-1986. Forty-four patients were treated with /sup 137/Cs and 21 were treated with /sup 252/Cf at equivalent doses of radiation. Fifteen of the 44 specimens (34%) were positive after 137Cs therapy. Only one of the 21 specimens was positive after /sup 252/Cf therapy (P = .025), and that patient was treated in a delayed schedule 21 days after the start of external-beam irradiation rather than early in the course. /sup 252/Cf therapy required a much lower radiation dose and shorter treatment time. The study compared tumor destruction of an identically staged human cervical tumor in situ by direct histological means, using /sup 252/Cf neutron therapy or conventional photon therapy at an identical and equivalent dose adjusted by a relative biological effectiveness of 6.0 for /sup 252/Cf.

Research Organization:
Univ. of Kentucky Medical Center, Lexington (USA)
OSTI ID:
6937769
Journal Information:
JNCI, J. Natl. Cancer Inst.; (United States), Journal Name: JNCI, J. Natl. Cancer Inst.; (United States) Vol. 80:7; ISSN JJIND
Country of Publication:
United States
Language:
English